Release of iron from phagocytosed Escherichia coli and uptake by neutrophil lactoferrin.

Abstract:

:Escherichia coli were labeled with 59Fe and then either treated with myeloperoxidase, H2O2, and chloride or opsonized and mixed with human neutrophils. The myeloperoxidase system at pH 7.4 caused release of most of the bacterial 59Fe. A similar result has been obtained by Rosen and Klebanoff (J Biol Chem 257:13731, 1982) but at pH 5. Iron release at pH 7.4 did not require the presence of a chelator, and the majority passed through a 10,000 relative molecular mass cut-off ultrafiltration membrane. When iron-poor lactoferrin was present during incubation with myeloperoxidase, 88% of the released 59Fe was precipitated with anti-lactoferrin antiserum, indicating that it was lactoferrin-bound. When the bacteria were mixed with neutrophils in a 10:1 ratio, approximately 50% were phagocytosed. About 40% of the 59Fe was released from the ingested bacteria over a 40-minute period. Initially, most remained associated with the neutrophil phagosomes, but with time, there was gradual transfer of some of the iron to the medium. Using anti-lactoferrin antiserum, 50% to 60% of phagosomal iron and 64% to 71% of iron in the medium was shown to be bound to lactoferrin. Thus, iron is released from phagocytosed E coli. Most becomes bound to lactoferrin, and some of this is released into the surroundings of the neutrophils. This suggests that neutrophil lactoferrin may function to trap iron from ingested microorganisms, enabling its removal from sites of inflammation. This may prevent iron from catalyzing undesirable oxidative reactions, as well as making it unavailable for growth of microorganisms that survive the killing process.

journal_name

Blood

journal_title

Blood

authors

Molloy AL,Winterbourn CC

subject

Has Abstract

pub_date

1990-02-15 00:00:00

pages

984-9

issue

4

eissn

0006-4971

issn

1528-0020

journal_volume

75

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy.

    abstract::Although thalidomide (Thal) was initially used to treat multiple myeloma (MM) because of its known antiangiogenic effects, the mechanism of its anti-MM activity is unclear. These studies demonstrate clinical activity of Thal against MM that is refractory to conventional therapy and delineate mechanisms of anti-tumor a...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Hideshima T,Chauhan D,Shima Y,Raje N,Davies FE,Tai YT,Treon SP,Lin B,Schlossman RL,Richardson P,Muller G,Stirling DI,Anderson KC

    更新日期:2000-11-01 00:00:00

  • Alternatively activated macrophages engage in homotypic and heterotypic interactions through IL-4 and polyamine-induced E-cadherin/catenin complexes.

    abstract::Alternatively activated macrophages (AAMs), triggered by interleukin-4 (IL-4) and IL-13, play a modulating role during Th2 cytokine-driven pathologies, but their molecular armament remains poorly characterized. Here, we established E-cadherin (Cdh1) as a selective marker for IL-4/IL-13-exposed mouse and human macropha...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-05-221598

    authors: Van den Bossche J,Bogaert P,van Hengel J,Guérin CJ,Berx G,Movahedi K,Van den Bergh R,Pereira-Fernandes A,Geuns JM,Pircher H,Dorny P,Grooten J,De Baetselier P,Van Ginderachter JA

    更新日期:2009-11-19 00:00:00

  • Intersubunit circular permutation of human hemoglobin.

    abstract::For many years, human hemoglobin (Hb) isolated from erythrocytes has been investigated as a potential oxygen delivery therapeutic. Advantages with respect to the need for blood typing were balanced with various undesirable properties of cell-free Hb, including cost, overall oxygen affinity, alterations in cooperativit...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v100.1.299

    authors: Sanders KE,Lo J,Sligar SG

    更新日期:2002-07-01 00:00:00

  • Erythropoietin stimulates a rise in intracellular-free calcium concentration in single BFU-E derived erythroblasts at specific stages of differentiation.

    abstract::Human cord blood progenitor-derived erythroblasts have recently been shown to respond to erythropoietin (Epo) or granulocyte-macrophage colony-stimulating factor (GM-CSF) with a transient increase in intracellular free calcium concentration [Cac]. However, the importance of [Cac] changes in mediating cell proliferatio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Miller BA,Cheung JY,Tillotson DL,Hope SM,Scaduto RC Jr

    更新日期:1989-04-01 00:00:00

  • cAMP-induced secretion of endothelial von Willebrand factor is regulated by a phosphorylation/dephosphorylation switch in annexin A2.

    abstract::The large multimeric glyocoprotein von Willebrand factor (VWF) is a crucial component of both primary and secondary hemostasis. It is stored in secretory granules of vascular endothelial cells, the Weibel-Palade bodies (WPBs), and is released following stimulation by agonists that raise intracellular Ca(2+) or cyclic ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-12-475251

    authors: Brandherm I,Disse J,Zeuschner D,Gerke V

    更新日期:2013-08-08 00:00:00

  • The hematopoietic stem cell niche in homeostasis and disease.

    abstract::The bone marrow microenvironment contains a heterogeneous population of stromal cells organized into niches that support hematopoietic stem cells (HSCs) and other lineage-committed hematopoietic progenitors. The stem cell niche generates signals that regulate HSC self-renewal, quiescence, and differentiation. Here, we...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2015-07-533588

    authors: Calvi LM,Link DC

    更新日期:2015-11-26 00:00:00

  • Selective binding of the factor VIII/von Willebrand factor protein to human platelets.

    abstract::The factor VIII/von Willebrand factor protein was radiolabeled after modification by galactose oxidase and reduction with tritiated potassium borohydride. This mild efficient method for labeling resulted in retention of over 90% of the biologic activities of the factor VIII/von Willebrand factor protein. Binding of th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Morisato DK,Gralnick HR

    更新日期:1980-01-01 00:00:00

  • Tandem autologous stem cell transplantation in high-risk de novo multiple myeloma: final results of the prospective and randomized IFM 99-04 protocol.

    abstract::The combination of high levels of beta2-microglobulin (beta2-m) and chromosome 13 deletion allows identification of a high-risk subgroup of patients with de novo multiple myeloma (MM). In this population of patients, we have evaluated the impact of a murine anti-interleukin 6 (anti-IL-6) monoclonal antibody (BE-8) as ...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2005-06-2573

    authors: Moreau P,Hullin C,Garban F,Yakoub-Agha I,Benboubker L,Attal M,Marit G,Fuzibet JG,Doyen C,Voillat L,Berthou C,Ketterer N,Casassus P,Monconduit M,Michallet M,Najman A,Sotto JJ,Bataille R,Harousseau JL,Intergroupe Fran

    更新日期:2006-01-01 00:00:00

  • Autoimmune neutropenia.

    abstract::There have been several new developments in the field of autoimmune neutropenia over the past decade. Neutropenia caused by antibodies directed against granulocyte precursor cells, the oligoclonal nature of antineutrophil antibodies, and the expanding knowledge of neutrophil antigens, particularly in relationship to a...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:

    authors: Shastri KA,Logue GL

    更新日期:1993-04-15 00:00:00

  • Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges.

    abstract::Recombinant human granulocyte colony-stimulating factor (rhG-CSF) is widely used in healthy donors for collection of peripheral blood progenitor cells (PBPCs) for allogeneic transplantation and granulocytes for transfusion. The spectrum of its biologic and molecular activities in healthy individuals is coming into sha...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2007-07-097543

    authors: Anderlini P,Champlin RE

    更新日期:2008-02-15 00:00:00

  • Immunogenic nature of a Pol gene product of HTLV-III/LAV.

    abstract::The present studies were initiated to define the coding region of a 34 kilodalton (kd) protein (p34) frequently observed with antibodies from HTLV-III/LAV-infected people by immunoblotting and radioimmunoprecipitation (RIP) techniques. We have directly mapped this viral protein to the pol gene of HTLV-III/LAV by radio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Allan JS,Coligan JE,Lee TH,Barin F,Kanki PJ,M'Boup S,McLane MF,Groopman JE,Essex M

    更新日期:1987-01-01 00:00:00

  • Reticulocyte-secreted exosomes bind natural IgM antibodies: involvement of a ROS-activatable endosomal phospholipase iPLA2.

    abstract::Reticulocytes release small membrane vesicles termed exosomes during their maturation into erythrocytes. It has been suggested that reticulocytes remodel the plasma membrane of the immature red cell during erythropoiesis by specifically eliminating various proteins. We report here that exosome release is associated wi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-04-085845

    authors: Blanc L,Barres C,Bette-Bobillo P,Vidal M

    更新日期:2007-11-01 00:00:00

  • Effects of paraprotein heavy and light chain types and free light chain load on survival in myeloma: an analysis of patients receiving conventional-dose chemotherapy in Medical Research Council UK multiple myeloma trials.

    abstract::While investigating 2592 patients enrolled in multicenter myeloma trials, we found light chain-only (LCO) patients had worse median survival times (1.9 years) than patients with IgA and IgG paraproteins (2.3 and 2.5 years, respectively) (P < .001). However, IgA and IgG patients with levels of LC excretion similar to t...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1182/blood-2006-03-008953

    authors: Drayson M,Begum G,Basu S,Makkuni S,Dunn J,Barth N,Child JA

    更新日期:2006-09-15 00:00:00

  • Monoclonal antibody targeting of IL-3 receptor α with CSL362 effectively depletes CML progenitor and stem cells.

    abstract::Despite the remarkable efficacy of tyrosine kinase inhibitors (TKIs) in eliminating differentiated chronic myeloid leukemia (CML) cells, recent evidence suggests that leukemic stem and progenitor cells (LSPCs) persist long term, which may be partly attributable to cytokine-mediated resistance. We evaluated the express...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-12-475194

    authors: Nievergall E,Ramshaw HS,Yong AS,Biondo M,Busfield SJ,Vairo G,Lopez AF,Hughes TP,White DL,Hiwase DK

    更新日期:2014-02-20 00:00:00

  • High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation.

    abstract::In lymphatic tissues, chronic lymphocytic leukemia (CLL) cells are interspersed with CD68(+) nurselike cells (NLCs), T cells, and other stromal cells that constitute the leukemia microenvironment. However, the mechanism regulating colocalization of CLL and these accessory cells are largely unknown. To dissect the mole...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-07-170415

    authors: Burger JA,Quiroga MP,Hartmann E,Bürkle A,Wierda WG,Keating MJ,Rosenwald A

    更新日期:2009-03-26 00:00:00

  • Quantitative trait locus on chromosome 8q influences the switch from fetal to adult hemoglobin.

    abstract::The switch from fetal to adult hemoglobin is incomplete; the residual fetal hemoglobin in adults is restricted to a subset of erythrocytes called F cells. F-cell levels are influenced by a sequence variant (C-->T) at position -158 upstream of the gamma-globin gene, termed the XmnI-Ggamma polymorphism. How the Ggamma-1...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-02-0527

    authors: Garner C,Silver N,Best S,Menzel S,Martin C,Spector TD,Thein SL

    更新日期:2004-10-01 00:00:00

  • Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.

    abstract::Because the causes of most lymphoid neoplasms remain unknown, comparison of incidence patterns by disease subtype may provide critical clues for future etiologic investigations. We therefore conducted a comprehensive assessment of 114,548 lymphoid neoplasms diagnosed during 1992-2001 in 12 Surveillance, Epidemiology, ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-06-2508

    authors: Morton LM,Wang SS,Devesa SS,Hartge P,Weisenburger DD,Linet MS

    更新日期:2006-01-01 00:00:00

  • The role of apoptosis in the development of AGM hematopoietic stem cells revealed by Bcl-2 overexpression.

    abstract::Apoptosis is an essential process in embryonic tissue remodeling and adult tissue homeostasis. Within the adult hematopoietic system, it allows for tight regulation of hematopoietic cell subsets. Previously, it was shown that B-cell leukemia 2 (Bcl-2) overexpression in the adult increases the viability and activity of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-06-1827

    authors: Orelio C,Harvey KN,Miles C,Oostendorp RA,van der Horn K,Dzierzak E

    更新日期:2004-06-01 00:00:00

  • Crystal structure and collagen-binding site of immune inhibitory receptor LAIR-1: unexpected implications for collagen binding by platelet receptor GPVI.

    abstract::Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1), one of the most widely spread immune receptors, attenuates immune cell activation when bound to specific sites in collagen. The collagen-binding domain of LAIR-1 is homologous to that of glycoprotein VI (GPVI), a collagen receptor crucial for platelet activ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-10-246322

    authors: Brondijk TH,de Ruiter T,Ballering J,Wienk H,Lebbink RJ,van Ingen H,Boelens R,Farndale RW,Meyaard L,Huizinga EG

    更新日期:2010-02-18 00:00:00

  • Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemia.

    abstract::In children with acute lymphoblastic leukemia (ALL), the level of minimal residual disease (MRD) at the end of induction strongly predicts outcome, presumably because it measures both drug sensitivity and the number of leukemic cells requiring elimination. Children with high levels (> 10(-3) leukemic cells per marrow ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:

    authors: Brisco J,Hughes E,Neoh SH,Sykes PJ,Bradstock K,Enno A,Szer J,McCaul K,Morley AA

    更新日期:1996-06-15 00:00:00

  • Donor T-cell alloreactivity against host thymic epithelium limits T-cell development after bone marrow transplantation.

    abstract::Acute graft-versus-host disease (aGVHD) impairs thymus-dependent T-cell regeneration in recipients of allogeneic bone marrow transplants through yet to be defined mechanisms. Here, we demonstrate in mice that MHC-mismatched donor T cells home into the thymus of unconditioned recipients. There, activated donor T cells ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-07-034157

    authors: Hauri-Hohl MM,Keller MP,Gill J,Hafen K,Pachlatko E,Boulay T,Peter A,Holländer GA,Krenger W

    更新日期:2007-05-01 00:00:00

  • A novel approach to preventing the hemolysis of paroxysmal nocturnal hemoglobinuria: both complement-mediated cytolysis and C3 deposition are blocked by a monoclonal antibody specific for the alternative pathway of complement.

    abstract::The clinical hallmark of paroxysmal nocturnal hemoglobinuria (PNH) is chronic intravascular hemolysis that is a consequence of unregulated activation of the alternative pathway of complement (APC). Intravascular hemolysis can be inhibited in patients by treatment with eculizumab, a monoclonal antibody that binds compl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-09-244285

    authors: Lindorfer MA,Pawluczkowycz AW,Peek EM,Hickman K,Taylor RP,Parker CJ

    更新日期:2010-03-18 00:00:00

  • Abnormal expression of the B-cell homing chemokine receptor BLR1 during the progression of acquired immunodeficiency syndrome.

    abstract::The putative chemokine receptor BLR1 has been identified as the first G-protein-coupled receptor involved in B-cell migration and in microenvironmental homing to B-cell follicles and to germinal centers. In healthy individuals, expression of BLR1 is restricted to all mature recirculating B cells and to a subpopulation...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Förster R,Schweigard G,Johann S,Emrich T,Kremmer E,Nerl C,Lipp M

    更新日期:1997-07-15 00:00:00

  • Interactions of GATA-2 with the promyelocytic leukemia zinc finger (PLZF) protein, its homologue FAZF, and the t(11;17)-generated PLZF-retinoic acid receptor alpha oncoprotein.

    abstract::Transcription factor GATA-2 is implicated in the survival and growth of multipotential progenitors. Here we report that the promyelocytic leukemia zinc finger (PLZF) protein can interact with GATA-2 and can modify its transactivation capacity. Fanconi anemia zinc finger (FAZF), a PLZF-homologous protein that has been ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.9.3404

    authors: Tsuzuki S,Enver T

    更新日期:2002-05-01 00:00:00

  • Identification of the dombrock blood group glycoprotein as a polymorphic member of the ADP-ribosyltransferase gene family.

    abstract::Identification of the 25 known human blood group molecules is of fundamental importance for the fields of erythroid cell biology and transfusion medicine. Here we provide the first molecular description of the "Dombrock" blood group system. A candidate gene was identified by in silico analyses of approximately 5000 ex...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gubin AN,Njoroge JM,Wojda U,Pack SD,Rios M,Reid ME,Miller JL

    更新日期:2000-10-01 00:00:00

  • TEL/PDGFbetaR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitor.

    abstract::The TEL/PDGFbetaR fusion protein is expressed as the consequence of a recurring t(5;12) translocation associated with chronic myelomonocytic leukemia (CMML). Unlike other activated protein tyrosine kinases associated with hematopoietic malignancies, TEL/PDGFbetaR is invariably associated with a myeloid leukemia phenot...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Tomasson MH,Williams IR,Hasserjian R,Udomsakdi C,McGrath SM,Schwaller J,Druker B,Gilliland DG

    更新日期:1999-03-01 00:00:00

  • High numbers of CD4+ T cells showing abnormal recognition of DR antigens in lymphoid organs involved by Hodgkin's disease.

    abstract::Purified T lymphocytes (E rosetting cells) isolated from the involved lymphoid organs (lymph nodes and spleen) of five patients with Hodgkin's disease (HD) were cloned under culture conditions (phytohemagglutinin plus interleukin-2) that allow clonal expansion of most T lymphocytes. A total number of 104 CD4+ T cell c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Maggi E,Parronchi P,Macchia D,Bellesi G,Romagnani S

    更新日期:1988-05-01 00:00:00

  • Translational control of c-MYC by rapamycin promotes terminal myeloid differentiation.

    abstract::c-MYC inhibits differentiation and regulates the process by which cells acquire biomass, cell growth. Down-regulation of c-MYC, reduced cell growth, and decreased activity of the PI3K/AKT/mTORC1 signal transduction pathway are features of the terminal differentiation of committed myeloid precursors to polymorphonuclea...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-09-111856

    authors: Wall M,Poortinga G,Hannan KM,Pearson RB,Hannan RD,McArthur GA

    更新日期:2008-09-15 00:00:00

  • Vitamin K antagonists in children with heart disease: height and VKORC1 genotype are the main determinants of the warfarin dose requirement.

    abstract::Managing vitamin K antagonist (VKA) therapy is challenging in children because of a narrow therapeutic range and wide inter- and intra-individual variability in dose response. Only a few small studies have investigated the effect of nongenetic and genetic factors on the dose response to VKAs in children. In a cohort s...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-07-365502

    authors: Moreau C,Bajolle F,Siguret V,Lasne D,Golmard JL,Elie C,Beaune P,Cheurfi R,Bonnet D,Loriot MA

    更新日期:2012-01-19 00:00:00

  • Depletion of the C3 component of complement enhances the ability of rituximab-coated target cells to activate human NK cells and improves the efficacy of monoclonal antibody therapy in an in vivo model.

    abstract::Growing evidence indicates antibody-dependent cellular cytotoxicity (ADCC) contributes to the clinical response to monoclonal antibody (mAb) therapy of lymphoma. Recent in vitro analysis suggests C3b can inhibit mAb-induced natural killer (NK)-cell activation and ADCC. Further studies were conducted to assess the effe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-01-200469

    authors: Wang SY,Veeramani S,Racila E,Cagley J,Fritzinger DC,Vogel CW,St John W,Weiner GJ

    更新日期:2009-12-17 00:00:00